|
1
1
|
Novartis AG |
0
1
2
3
4
5
|
3.86 | |
|
2
2
|
GSK plc |
0
1
2
3
4
5
|
3.73 | |
|
3
5
|
AstraZeneca plc |
0
1
2
3
4
5
|
3.28 | |
|
4
3
|
Sanofi |
0
1
2
3
4
5
|
3.17 | |
|
5
10
|
Bayer AG |
0
1
2
3
4
5
|
3.15 | |
|
6
8
|
Boehringer Ingelheim |
0
1
2
3
4
5
|
3.11 | |
|
6
11
|
Roche Holding AG |
0
1
2
3
4
5
|
3.11 | |
|
8
4
|
Pfizer Inc |
0
1
2
3
4
5
|
2.96 | |
|
9
7
|
Merck KGaA |
0
1
2
3
4
5
|
2.81 | |
|
10
9
|
Takeda Pharmaceutical Co, Ltd |
0
1
2
3
4
5
|
2.72 | |
|
11
12
|
Novo Nordisk A/S |
0
1
2
3
4
5
|
2.67 | |
|
12
13
|
Bristol Myers Squibb |
0
1
2
3
4
5
|
2.34 | |
|
13
5
|
Johnson & Johnson |
0
1
2
3
4
5
|
2.26 | |
|
14
14
|
Eisai Co, Ltd |
0
1
2
3
4
5
|
2.25 | |
|
15
16
|
Merck & Co, Inc |
0
1
2
3
4
5
|
2.14 | |
|
16
16
|
Gilead Sciences |
0
1
2
3
4
5
|
2.03 | |
|
17
15
|
Astellas Pharma Inc |
0
1
2
3
4
5
|
1.67 | |
|
18
19
|
Eli Lilly & Co |
0
1
2
3
4
5
|
1.66 | |
|
19
18
|
Daiichi Sankyo Co, Ltd |
0
1
2
3
4
5
|
1.65 | |
|
20
20
|
AbbVie Inc |
0
1
2
3
4
5
|
1.29 |
0
1
2
3
4
5
|
The ranking above shows the position and score of each company in the 2026 Index (left) and 2024 Index (right). Click on a company's name to go to its full report card.